Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Svenningsson

Showing results (11-20 of 441) with videos related to

Pageof 45
Sort By:
International Journal of Molecular Sciences|June 2, 2021
Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson's DiseaseJohan Wallin, Per Svenningsson
Annual Review of Pharmacology and Toxicology|October 5, 2010
Modulation of monoamine receptors by adaptor proteins and lipid rafts: role in some effects of centrally acting drugs and therapeutic agentsKarl Björk, Per Svenningsson
Current Opinion in Neurology|May 10, 2021
Update on alpha-synuclein-based biomarker approaches in the skin, submandibular gland, gastrointestinal tract, and biofluidsMattias Andréasson, Per Svenningsson
Parkinsonism & Related Disorders|July 21, 2023
Elevated ApoE, ApoJ and lipoprotein-bound α-synuclein levels in cerebrospinal fluid from Parkinson's disease patients - Validation in the BioFIND cohortWojciech Paslawski, Per Svenningsson
Trends in Pharmacological Sciences|May 19, 2020
Modulation of Ion Channels and Receptors by p11 (S100A10)Ji-Seon Seo, Per Svenningsson
Current Opinion in Neurology|June 28, 2019
Editorial: Update on movement disordersPer Svenningsson, Steven J Frucht
The European Journal of Neuroscience|February 28, 2002
Dopamine D1/5 receptor stimulation induces c-fos expression in the subthalamic nucleus: possible involvement of local D5 receptorsPer Svenningsson, Catherine Le Moine
Sleep Medicine Clinics|September 5, 2025
Clinical and Biofluid Biomarkers of Sleep Dysfunction in Parkinson's DiseaseRuy Gómez-Ocádiz, Per Svenningsson
Neurology|December 10, 2003
Adenosine-dopamine interactions: development of a concept and some comments on therapeutic possibilitiesBertil B Fredholm, Per Svenningsson
Neurology|December 10, 2003
Exciting news about A2A receptorsPer Svenningsson, Bertil B Fredholm
Pageof 45

Showing results (11-20 of 441) with videos related to

Sort By:
Pageof 45
International Journal of Molecular Sciences|June 2, 2021
Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson's DiseaseJohan Wallin, Per Svenningsson
Annual Review of Pharmacology and Toxicology|October 5, 2010
Modulation of monoamine receptors by adaptor proteins and lipid rafts: role in some effects of centrally acting drugs and therapeutic agentsKarl Björk, Per Svenningsson
Current Opinion in Neurology|May 10, 2021
Update on alpha-synuclein-based biomarker approaches in the skin, submandibular gland, gastrointestinal tract, and biofluidsMattias Andréasson, Per Svenningsson
Parkinsonism & Related Disorders|July 21, 2023
Elevated ApoE, ApoJ and lipoprotein-bound α-synuclein levels in cerebrospinal fluid from Parkinson's disease patients - Validation in the BioFIND cohortWojciech Paslawski, Per Svenningsson
Trends in Pharmacological Sciences|May 19, 2020
Modulation of Ion Channels and Receptors by p11 (S100A10)Ji-Seon Seo, Per Svenningsson
Current Opinion in Neurology|June 28, 2019
Editorial: Update on movement disordersPer Svenningsson, Steven J Frucht
The European Journal of Neuroscience|February 28, 2002
Dopamine D1/5 receptor stimulation induces c-fos expression in the subthalamic nucleus: possible involvement of local D5 receptorsPer Svenningsson, Catherine Le Moine
Sleep Medicine Clinics|September 5, 2025
Clinical and Biofluid Biomarkers of Sleep Dysfunction in Parkinson's DiseaseRuy Gómez-Ocádiz, Per Svenningsson
Neurology|December 10, 2003
Adenosine-dopamine interactions: development of a concept and some comments on therapeutic possibilitiesBertil B Fredholm, Per Svenningsson
Neurology|December 10, 2003
Exciting news about A2A receptorsPer Svenningsson, Bertil B Fredholm
Pageof 45